Atlas Trials

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

Clinical trial NCT02032784 · TERMINATED

Trial details

NCT number
NCT02032784
Sponsor
AdventHealth
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Adenoma
Start date
2014-03-01
Primary completion
2018-06-28
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.